BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24782851)

  • 1. Counteraction of the multifunctional restriction factor tetherin.
    Sauter D
    Front Microbiol; 2014; 5():163. PubMed ID: 24782851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
    Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
    PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
    Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.
    Blanchet FP; Stalder R; Czubala M; Lehmann M; Rio L; Mangeat B; Piguet V
    Retrovirology; 2013 Jan; 10():6. PubMed ID: 23311681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
    Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK
    Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
    Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetherin Antagonism by HIV-1 Group M Nef Proteins.
    Arias JF; Colomer-Lluch M; von Bredow B; Greene JM; MacDonald J; O'Connor DH; Serra-Moreno R; Evans DT
    J Virol; 2016 Dec; 90(23):10701-10714. PubMed ID: 27654287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
    Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
    PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor.
    Swiecki M; Omattage NS; Brett TJ
    Mol Immunol; 2013 Jun; 54(2):132-9. PubMed ID: 23274150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
    Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
    Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.
    Schmidt S; Fritz JV; Bitzegeio J; Fackler OT; Keppler OT
    mBio; 2011; 2(3):e00036-11. PubMed ID: 21610122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In COS cells Vpu can both stabilize tetherin expression and counteract its antiviral activity.
    Waheed AA; Kuruppu ND; Felton KL; D'Souza D; Freed EO
    PLoS One; 2014; 9(10):e111628. PubMed ID: 25360760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Tetherin Inhibition of Alphavirus Release.
    Wan JJ; Ooi YS; Kielian M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
    J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.